share_log

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Benzinga ·  May 11, 2023 21:06

Gainers

  • Sunshine Biopharma (NASDAQ:SBFM) shares rose 45.1% to $0.77 during Thursday's pre-market session. The company's market cap stands at $17.3 million.
  • Jaguar Health (NASDAQ:JAGX) stock rose 28.19% to $0.92. The company's market cap stands at $12.7 million.
  • Ampio Pharmaceuticals (AMEX:AMPE) shares increased by 23.91% to $0.25. The company's market cap stands at $3.7 million.
  • Tivic Health Systems (NASDAQ:TIVC) stock rose 18.32% to $0.2. The company's market cap stands at $5.7 million.
  • PharmaCyte Biotech (NASDAQ:PMCB) stock increased by 15.69% to $3.17. The market value of their outstanding shares is at $55.2 million.
  • Assure Hldgs (NASDAQ:IONM) stock rose 15.33% to $1.88. The company's market cap stands at $2.0 million. As per the news, the Q1 earnings report came out yesterday.

Losers

  • ImmunityBio (NASDAQ:IBRX) shares decreased by 54.5% to $2.83 during Thursday's pre-market session. The market value of their outstanding shares is at $1.2 billion.
  • Biophytis (NASDAQ:BPTS) shares decreased by 17.54% to $2.68. The market value of their outstanding shares is at $8.3 million.
  • CareDx (NASDAQ:CDNA) shares fell 17.35% to $7.1. The market value of their outstanding shares is at $381.9 million. As per the news, the Q1 earnings report came out yesterday.
  • Matinas BioPharma Hldgs (AMEX:MTNB) shares decreased by 16.42% to $0.56. The company's market cap stands at $121.6 million. As per the news, the Q1 earnings report came out yesterday.
  • Pharming (NASDAQ:PHAR) stock declined by 13.42% to $11.1. The market value of their outstanding shares is at $728.5 million. As per the press release, Q1 earnings came out today.
  • Vyant Bio (NASDAQ:VYNT) shares decreased by 12.5% to $0.33. The market value of their outstanding shares is at $2.0 million. See Also:

This article was generated by Benzinga's automated content engine and reviewed by an editor.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment